Literature DB >> 6940423

Coronary risk factors and physical fitness in healthy middle-aged men.

J Erikssen, K Forfang, J Jervell.   

Abstract

In 1832 healthy men aged 40-59 years subjected to a near maximal bicycle exercise test, physical fitness decline with age. Higher levels of physical fitness were in all age groups associated with lower cigarette consumption, blood pressure, serum triglycerides, hemoglobin and with better pulmonary function. Serum cholesterol, however, was independent of changes in physical fitness. In view of the beneficial effect of high physical activity on the well-known coronary risk factors, it is surprising that it has proved so difficult to show a protective effect of increased physical fitness and activity in coronary heart disease and its manifestations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6940423     DOI: 10.1111/j.0954-6820.1981.tb02601.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  5 in total

Review 1.  Adolphe Abrahams memorial lecture, 1988. Exercise and lifestyle change.

Authors:  R J Shephard
Journal:  Br J Sports Med       Date:  1989-03       Impact factor: 13.800

Review 2.  Life style as a blood pressure determinant.

Authors:  J A Staessen; L Bieniaszewski; K Pardaens; V Petrov; L Thijs; R Fagard
Journal:  J R Soc Med       Date:  1996-09       Impact factor: 5.344

3.  The Tromsø study: physical fitness, self reported physical activity, and their relationship to other coronary risk factors.

Authors:  M L Løchen; K Rasmussen
Journal:  J Epidemiol Community Health       Date:  1992-04       Impact factor: 3.710

4.  The impact of exercise upon medical costs.

Authors:  R J Shephard
Journal:  Sports Med       Date:  1985 Mar-Apr       Impact factor: 11.136

5.  Assessment of physical activity by questionnaire and personal interview with particular reference to fitness and coronary mortality.

Authors:  R Mundal; J Erikssen; K Rodahl
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.